“Low quantity, fragment heterogeneity, false results and analytical difficulties are some common limitations of using ctDNA as a biomarker.” Circulating tumor DNA is free fragments of DNA released by tumor […]
Limitations of ctDNA as a Biomarker Read More »
“Circulating tumor DNA is present in the bloodstream and secreted by cancer cells. Recent studies suggest that scientists use these DNA fragments to study cancer. But is ctDNA a biomarker?
Is ctDNA a Biomarker? Read More »
“Microsatellite instability is defined as indel (insertion or deletion) mutations within the repetitive regions (microsatellite) in cancer cells by the inactivation of DNA mismatch repair proteins.“ Do you know? Introns
Role of Microsatellite Instability (MSI) in cancer (MSI-H, MSI-I and MSS) Read More »
